MedPath

Clinical efficacy of psychological intervention combined with acupuncture in treating liver depression PMS based on QOL-BREF and ERP

Phase 1
Recruiting
Conditions
premenstrual syndrome
Registration Number
ITMCTR1900002374
Lead Sponsor
niversity of Science and Technology of China
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) referring to the journal of obstetrics and gynecology for premenstrual syndrome (premenstrual syndrome, PMS) in the diagnosis of: the main symptoms: physical symptoms: headaches, back pain, breast pain, etc.;Mental symptoms: irritability, anxiety, emotional instability, etc.Behavior change: inattention, low work efficiency, excitable, etc.(2) combined with Zhong Tianming wait the revised Allen of premenstrual symptoms such as compiling touting (shortened premenstrual assessment form, SPAF), the scale, a total of 10 entries, level 6 score, 1 minute, said no, said very serious six points, total score 10 to 60 minutes.As the demarcation score, individuals with scores higher than 30 are considered to have PMS.The lower the score, the less severe PMS symptoms;
(3) between 18 and 40 years old;
(4) with clear consciousness and willing to cooperate;
(5) regular menstrual cycle, 21-35 days;
(6) SPAF screening symptoms occurred more than three consecutive menstrual cycles, during which no psychotropic drugs or contraceptives were used for more than three months;
(7) signing the informed consent.

Exclusion Criteria

(1) women in pregnancy or lactation or perimenopause;
(2) patients with mental diseases, liver and kidney diseases, cardiovascular and cerebrovascular diseases, pulmonary diseases or hematopoietic diseases;
(3) history of oral contraceptives and hormone use within 3 months before the visit;
(4) a history of alcohol intoxication or substance abuse within 6 to 12 months before the visit;
(5) patients with acupuncture taboos;
(6) failing to sign the informed consent;
(7) fail to complete the whole treatment process.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
State-Trait Anxiety;score of shortened premenstrual assessment form;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath